Cutler Group’s Celldex Therapeutics CLDX Stock Holding History

Cutler Group’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-600	Closed	-$1K	–	3845
2023 Q2	$1K	Buy	+600	New	+$20.2K	﹤0.01%	3216
2022 Q3	–	Sell	-38,100	Closed	-$182K	–	4969
2022 Q2	$182K	Buy	38,100 +34,700	+1,021%	+$1.01M	0.01%	1069
2022 Q1	$12K	Buy	3,400 +2,000	+143%	+$63.9K	﹤0.01%	3451
2021 Q4	$4K	Sell	1,400 -26,100	-95%	-$1.14M	﹤0.01%	4308
2021 Q3	$114K	Buy	+27,500	New	+$1.29M	0.01%	1808
2017 Q3	–	Sell	-1,600	Closed	-$1K	–	5935
2017 Q2	$1K	Sell	1,600 -260	-14%	-$11.5K	﹤0.01%	5803
2017 Q1	$6K	Sell	1,860 -1,747	-48%	-$91K	﹤0.01%	4514
2016 Q4	$14K	Buy	3,607 +1,714	+91%	+$97.5K	﹤0.01%	3816
2016 Q3	$19K	Sell	1,893 -187	-9%	-$11.6K	﹤0.01%	3456
2016 Q2	$32K	Buy	2,080 +247	+13%	+$15.7K	﹤0.01%	2823
2016 Q1	$4K	Sell	1,833 -1,047	-36%	-$118K	﹤0.01%	5012
2015 Q4	$9K	Buy	+2,880	New	+$628K	﹤0.01%	4232

Other funds holding CLDX

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return